Study on calming severe agitation in psychiatric emergency rooms
Part of Brain & nervous system clinical trials.
This trial tests two different medications to quickly calm severe agitation in people admitted to a psychiatric emergency room. You may be able to join if you are extremely agitated and need urgent medication to help you settle down.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 64 years old.
- You are currently in a psychiatric emergency room or inpatient unit and need medication for severe agitation.
- You have a total score of at least 14 on a scale that measures agitation, with at least one symptom rated as severe.
- You are able to give your consent before the emergency treatment starts.
- You are not involuntarily admitted under the Danish Mental Health Act.
- If you are a female and could become pregnant, you must have a negative pregnancy test and use reliable birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining two sedative medications, esketamine and dexmedetomidine, is safer and more effective than using dexmedetomidine alone for treating hyperactive delirium in ICU patients who need breathing support. If you or a loved one are experiencing severe confusion and agitation while on a breathing machine, this study may offer a new treatment option.
This study tests two medications, haloperidol and dexmedetomidine, to see which works better for reducing confusion and agitation in patients who are on a breathing machine after a traumatic brain injury. If you or a loved one is in the ICU with a brain injury and is restless or confused, this trial may help find better ways to manage those symptoms.
This study tests whether a drug called dexmedetomidine (a sedative) can help calm patients with severe brain injury who are on a breathing machine in the intensive care unit. If you or your loved one is in this situation, this treatment might reduce agitation and improve recovery.
This study tests a multi-step program to prevent and lessen agitation in ICU patients, with the goal of reducing the need for physical restraints. It also aims to improve comfort and safety during a longer ICU stay.
This study tests whether a medication called dexmedetomidine, given as a nasal spray, can quickly relieve sudden anxiety. The goal is to see if this approach works better or faster than current treatments for acute anxiety episodes.
This Phase 1 trial tests whether BXCL501 is safe and can help reduce agitation in children and teens who have bipolar disorder or schizophrenia. You may be considered if your agitation is significant during screening, but certain recent medication and health factors can make you ineligible.
Hear when a new Agitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.